Ten year survival and outcomes in a prospective cohort of new onset Chinese Parkinson's disease patients

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 83, Issue 6, 2012, Pages 607-611

  Auyeung, Man ^a   Tsoi, T H ^a   Mok, Vincent ^b   Cheung, C M ^a   Lee, C N ^a   Li, R ^a   Yeung, E ^a  

^a PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; SELEGILINE;

AGE DISTRIBUTION; ARTICLE; CHINESE; CLINICAL FEATURE; DISEASE COURSE; DYSPHAGIA; ESSENTIAL TREMOR; FALLING; FEMALE; FREEZING OF GAIT; GAIT DISORDER; HUMAN; INSTITUTIONALIZATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOTOR DYSFUNCTION; ONSET AGE; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; POSTURAL INSTABILITY GAIT DISORDER; PRIORITY JOURNAL; SPEECH DISORDER; SURVIVAL TIME;

ACCIDENTAL FALLS; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; COHORT STUDIES; DEGLUTITION DISORDERS; DEMENTIA; DISEASE PROGRESSION; FEMALE; GAIT DISORDERS, NEUROLOGIC; HALLUCINATIONS; HUMANS; HYPOTENSION, ORTHOSTATIC; MALE; MIDDLE AGED; PARKINSON DISEASE; RISK FACTORS; SPEECH DISORDERS; SURVIVAL ANALYSIS;

EID: 84862792301     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2011-301590     Document Type: Article

References (27)

1. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-42.
2. Marttila RJ, Rinne UK, Siirtola T, et al. Mortality of patients with Parkinson's disease treated with levodopa. J Neurol 1977;216:147-53. (Pubitemid 8183813)
3. Ben-Shlomo Y, Marmot MG. Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology? J Neurol Neurosurg Psychiatry 1995;58:293-9.
4. Rajput AH, Offord KP, Beard CM, et al. Epidemiology of parkinsonism: incidence, classification, and mortality. Ann Neurol 1984;16:278-82. (Pubitemid 14041762)
5. Chen H, Zhang SM, Schwarzschild MA, et al. Survival of Parkinson's disease patients in a large prospective cohort of male health professionals. Mov Disord 2006;21:1002-7. (Pubitemid 44184603)
6. Hely MA, Morris J, Reid W, et al. The Sydney multicentre study of Parkinson's disease: progression and mortality at 10 years. J Neurol Neurosurg Psychiatry 1999;67:300-7. (Pubitemid 29392588)
7. Hughes TA, Ross HF, Mindham RHS, et al. Mortality in Parkinson's disease and its association with dementia and depression. Acta Neurol Scand 2004;110:118-23. (Pubitemid 39044049)
8. Herlofson K, Lie SA, Arsland D, et al. Mortality and Parkinson disease. A community based study. Neurology 2004;62:937-42. (Pubitemid 38435782)
9. Hely M, Morris JGL, Reid WGJ, et al. Sydney multicenter study of Parkinson's disease: non L-dopa-responsive problems dominate at 15 years. Mov Disord 2005;20:190-9. (Pubitemid 40361122)
10. Diamond SG, Markham CH, Hoehn MM, et al. Multi-center study of Parkinson mortality with early versus later dopa treatment. Ann Neurol 1987;22:8-12. (Pubitemid 17088740)
11. Hughes AJ, Daniel SE. Parkinson's Disease Society Brain Bank (PDSBB) criteria. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-4.
12. American Psychiatric Association Committee on Nomenclature and Statistics. Diagnostic and statistical manual of mental disorders (DSM-IV). 4th edn. Washington, DC: American Psychiatric Association, 1994.
13. Ury HK, Wiggins AD. Another shortcut method for calculating the confidence interval of a poisson variable (or of a standardized mortality ratio). Am J Epidemiol 1985;122:197-8.
14. Elbaz A, Bower JH, Peterson BJ, et al. Survival study of Parkinson disease in Olmsted County, Minnesota. Arch Neurol 2003;60:91-6. (Pubitemid 36078114)
15. Fall PA, Saleh A, Fredrickson M, et al. Survival time, mortality, and cause of death in elderly patients with Parkinson's disease: a 9-year follow-up. Mov Disord 2003;18:1312-16. (Pubitemid 38263316)
16. Diem-Zangerl A, Seppi K, Wenning GK, et al. Mortality in Parkinson's disease: a 20-year follow-up study. Mov Disord 2009;24:819-25.
17. Marras C, McDermott MP, Rochon PA, et al. The Parkinson Study Group. Survival in Parkinson disease. Thirteen-year follow-up of the DATATOP cohort. Neurology 2005;64:87-93. (Pubitemid 40082942)
18. Lo RY, Tanner CM, Albers KB, et al. Clinical features in early Parkinson disease and survival. Arch Neurol 2009;66:1353-8.
19. Forsaa EB, Larsen JP, Wentzel-Larsen T, et al. What predicts mortality in Parkinson disease? A prospective population-based long-term study. Neurology 2010;75:1270-6.
20. Rajput AH, Pahwa R, Pahwa P, et al. Prognostic significance of the onset mode in parkinsonism. Neurology 1993;43:829-30. (Pubitemid 23121983)
21. Horak FB, Frank J, Nutt J, et al. Effects of dopamine on postural control in Parkinsonian subjects: scaling, set, and tone. J Neurophysiol 1996;75: 2380-96. (Pubitemid 26200633)
22. Pahapill PA, Lozano AM. The pedunculopontine nucleus and Parkinson's disease. Brain 2000;123:1767-83. (Pubitemid 30664282)
23. Bohnen NI, Muller ML, Koeppe RA, et al. History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology 2009;73:1670-6.
24. Whitehouse PJ, Hedreen JC, White CL, et al. Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol 1983;13:243-8. (Pubitemid 13158530)
25. Burn DJ, Rowan EN, Allan LM, et al. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2006;77:585-9. (Pubitemid 43844579)
26. Alves G, Larsen JP, Emre M, et al. Changes in motor subtype and risk for incident dementia in Parkinson's disease. Mov Disord 2006;21:1123-30. (Pubitemid 44336596)
27. Chung KA, Lobb BM, Nutt JG, et al. Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology 2010;75:1263-9.